Snyder James G, Prewitt Russell, Campsen Jeff, Britt L D
Department of Surgery, Eastern Virginia Medical School, Norfolk 23507-1912, USA.
Shock. 2002 Apr;17(4):304-7. doi: 10.1097/00024382-200204000-00011.
NF-kappaB is a ubiquitous transcription factor that mediates the inflammatory response. Inhibition of NF-kappaB may be of potential therapeutic benefit in the treatment of septic shock. The antioxidant pyrrolidine dithiocarbamate (PDTC) has been shown in previous work to selectively inhibit NF-kappaB activation. Likewise, the proteasome inhibitor MG132 inhibits NF-kappaB formation and degradation of its inhibitor I-kappaB. The goal of this study was to determine if PDTC and MG-132 could inhibit resistance arteriole vasodilation in response to endotoxin and to determine PDTC's site of action in our isolated vessel preparation. Male Sprague-Dawley rats were given an intraperitoneal injection of PDTC, an intravenous injection of MG132, or a sham injection. First-order cremasteric arterioles were isolated, cannulated, and pressurized. A segment of thoracic aorta was then placed in series with the microvascular preparation. Vessels were allowed to achieve spontaneous myogenic tone in a bath of buffer over 1 h (t = 0). Internal vessel diameters were measured and the response to endotoxin (ET) or continued infusion of buffer was measured over 1 h (t = 60). Group 1 (n = 7) was a time-control group. Group 2 (n = 7) was exposed to ET only, Group 3 (n = 5) received PDTC and was exposed to ET, Group 4 (n = 5) received PDTC only, Group 5 (n = 4) received MG132 only, and Group 6 (n = 5) received MG132 and was exposed to ET. To determine the site of action of PDTC, a segment of aorta from an animal treated with PDTC was placed in series with a cremasteric arteriole from an animal receiving a sham injection. The preparation was then exposed to ET, and this is Group 7 (n = 4). Group 8 (n = 4) received ET and was composed of thoracic aorta from an animal receiving a sham injection and a cremasteric arteriole from a PDTC-treated animal. Spontaneous tone was similar in the eight groups at the end of the equilibration period (t = 0). After 1 h (t = 60), Group 2 (vessels exposed to ET only) had significantly less tone (26.1%+/-2.6%; P < 0.01) than Group 1 (39.0%+/-2.4%), Group 3 (39.3%+/-3.1%), Group 4 (41.2%+/-1.6%), Group 5 (39.2%+/-2.9%), Group 6 (41.0%+/-2.7%), Group 7 (45.1%+/-6.5%), and Group 8 (41.1%+/-4.5%). We conclude that PDTC and MG132, inhibitors of NF-kappaB, block ET-induced vasodilation in isolated rat skeletal muscle arterioles. PDTC has effects at both the level of the aortic segment as well as the resistance arteriole. Inhibitors of NF-kappaB may potentially be of therapeutic benefit in the treatment of septic shock.
核因子-κB是一种介导炎症反应的普遍存在的转录因子。抑制核因子-κB在治疗脓毒性休克中可能具有潜在的治疗益处。抗氧化剂吡咯烷二硫代氨基甲酸盐(PDTC)在先前的研究中已显示可选择性抑制核因子-κB的激活。同样,蛋白酶体抑制剂MG132可抑制核因子-κB的形成及其抑制剂I-κB的降解。本研究的目的是确定PDTC和MG-132是否能抑制内毒素引起的阻力小动脉血管舒张,并确定PDTC在我们分离的血管标本中的作用部位。给雄性Sprague-Dawley大鼠腹腔注射PDTC、静脉注射MG132或进行假注射。分离出一级提睾肌小动脉,插管并加压。然后将一段胸主动脉与微血管标本串联放置。使血管在缓冲液浴中1小时(t = 0)达到自发肌源性张力。测量血管内径,并在1小时(t = 60)内测量对内毒素(ET)或持续输注缓冲液的反应。第1组(n = 7)为时间对照组。第2组(n = 7)仅暴露于ET,第3组(n = 5)接受PDTC并暴露于ET,第4组(n = 5)仅接受PDTC,第5组(n = 4)仅接受MG132,第6组(n = 5)接受MG132并暴露于ET。为了确定PDTC的作用部位,将用PDTC处理的动物的一段主动脉与接受假注射的动物的提睾肌小动脉串联放置。然后将该标本暴露于ET,这是第7组(n = 4)。第8组(n = 4)接受ET,由接受假注射的动物的胸主动脉和用PDTC处理的动物的提睾肌小动脉组成。在平衡期结束时(t = 0),八组的自发张力相似。1小时后(t = 60),第2组(仅暴露于ET的血管)的张力(26.1%±2.6%;P < 0.01)明显低于第1组(39.0%±2.4%)、第3组(39.3%±3.1%)、第4组(41.2%±1.6%)、第5组(39.2%±2.9%)、第6组(41.0%±2.7%)、第7组(45.1%±6.5%)和第8组(41.1%±4.5%)。我们得出结论,核因子-κB抑制剂PDTC和MG132可阻断内毒素诱导的离体大鼠骨骼肌小动脉血管舒张。PDTC在主动脉段以及阻力小动脉水平均有作用。核因子-κB抑制剂在治疗脓毒性休克中可能具有潜在的治疗益处。